After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand. The New Brunswick, N.J.
Johnson & Johnson's COVID-19 vaccine has taken a back seat to mRNA programs from Pfizer and Moderna in many developed nations, but it's still in high demand around the world. That's why news the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results